| Ms Lida Margherita Strong, LCSW | |
|
534 Soquel Ave., Santa Cruz, CA 95062 | |
| (831) 423-7027 | |
| Not Available |
| Full Name | Ms Lida Margherita Strong |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 534 Soquel Ave., Santa Cruz, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063127751 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | LCSW9599 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Lida Margherita Strong, LCSW 534 Soquel Ave., Santa Cruz, CA 95062 Ph: () - | Ms Lida Margherita Strong, LCSW 534 Soquel Ave., Santa Cruz, CA 95062 Ph: (831) 423-7027 |
News Archive
In a study published today in the open-access journal The Lancet Global Health, the Drugs for Neglected Diseases initiative and other researchers report a persistent deficiency in truly new therapeutics for neglected diseases, despite nominal progress and an acceleration in research and development efforts. This continued 'fatal imbalance' in medical R&D points to the urgent need to develop and deliver groundbreaking new treatments for the world's poorest and most neglected patients.
It's an eye condition where genetics and environmental factors like ultraviolet light and vigorous eye rubbing conspire to make the usual curvature of the cornea more pointy, leaving us with double vision and nearsighted.
Health insurers' outlook continues to be negative as the sector faces new regulations, heightened political pressure and a weak economy, which are expected to squeeze earnings, one major ratings agency said (Evans, 1/4).
Results from two concurrent, prospective, double-blind, multi-center clinical trials show that pegaptanib (Macugen), an anti-vascular endothelial growth factor therapy, is an effective treatment for neovascular age-related macular degeneration (AMD), according to a paper in the Dec. 30 issue of the New England Journal of Medicine. Macugen was approved by the Food and Drug Administration on Dec. 17.
› Verified 6 days ago
Ms. Sandra Maura, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 103 Wavecrest Ave, Santa Cruz, CA 95060 Phone: 831-425-5971 Fax: 831-425-5971 | |
Ms. Cassandra Dobrin, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 524 Western Dr, Santa Cruz, CA 95060 Phone: 831-706-7577 | |
Callia Hansen, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1510 Capitola Rd, Santa Cruz, CA 95062 Phone: 831-427-3500 | |
Craig Rothhammer, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1400 Emeline Ave, Santa Cruz, CA 95060 Phone: 831-454-4170 Fax: 831-454-4663 | |
Lisa M Howe, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 206 Pelton Ave, Santa Cruz, CA 95060 Phone: 831-239-2147 | |
Jennifer Sredniawa, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1080 Emeline Ave, Santa Cruz, CA 95060 Phone: 831-454-4100 | |
Steve E. Macy, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1400 Emeline Ave, Santa Cruz, CA 95060 Phone: 831-454-4276 |